Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 5/20 | 0.30 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19239929 | 0.85 | PTPN1 (0.36) | GAAALDH1A1OPRM1OPRL1 | |
| SCHEMBL18161032 | 0.81 | GAA (0.33) | GAAALDH1A1OPRM1OPRL1DPP4 | |
| SCHEMBL26316144 | 0.76 | DPP4 (0.32) | GAADPP4 | |
| SCHEMBL19239928 | 0.76 | KDM5A (0.32) | GAA | |
| SCHEMBL19999715 | 0.75 | KDM5A (0.33) | GAAALDH1A1 | |
| SCHEMBL681442 | 0.72 | CPN1 (0.33) | ALDH1A1 | |
| SCHEMBL21431247 | 0.72 | GAA (0.34) | GAAOPRL1 | |
| SCHEMBL21573595 | 0.71 | MEN1 (0.31) | ALDH1A1 | |
| SCHEMBL17995186 | 0.71 | CCR2 (0.33) | GAAALDH1A1OPRL1DPP4DPP8 | |
| SCHEMBL17540515 | 0.70 | KDM4E (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2842576-B1 | Transglutaminase mediated conjugation of peptides | NOVO NORDISK HEALTHCARE AG (CH) | 2017-06-28 | — | — | EP | disclosed |